Clinical Trial Update: Direct Acting Antiviral Therapy in Donor HCV-positive to Recipient HCV-negative Kidney Transplant [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating direct-acting antiviral therapy for donor HCV-positive to recipient HCV-negative kidney transplants has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Kidney Diseases
• Kidney Failure

Snippet

Sponsor: Raymond T. Chung, MD | Conditions: Kidney Failure, Kidney Diseases | Phase 4 | Status: WITHDRAWN